DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

6.90 0.19 (2.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

FOLD $6.90 2.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.70
Previous Close $6.71
Daily Range $6.64 - $7.07
52-Week Range $1.77 - $7.63
Market Cap $543.0M
P/E Ratio -6.99
Dividend (Yield) $0.00 (0.0%)
Volume 1,333,094
Average Daily Volume 3,671,656
Current FY EPS -$0.89

Sector

Healthcare

Industry

Drugs

Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website: http://www.amicusrx.com/

News & Commentary

Why Amicus Therapeutics, Inc. Stock Is Soaring Today

Amicus Therapeutics' shares are soaring today. Here's why.

3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus

Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape

Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape

Top 5 Performing Biotech Stocks Of 2014

Morning Market Movers

Amicus Therapeutics (FOLD) Stock Rises on High Volume

Perilous Reversal Watch: Amicus Therapeutics (FOLD)

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog

The Biotech Stock With The Best One-Week Performance

Five Billionaire-Owned Biotech Stocks You Could Acquire for 100%

See More FOLD News...

FOLD's Top Competitors

FOLD $6.90 (2.83%)
Current stock: FOLD
AMGN $140.71 (0.99%)
Current stock: AMGN
GILD $103.84 (-0.88%)
Current stock: GILD
BIIB $327.58 (0.21%)
Current stock: BIIB